ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2018

Development and Validation of an Artificial Intelligence Approach for the Detection of Radiographic Sacroiliitis

Keno-Kyrill Bressem1, Janis Vahldiek1, Lisa Adams1, Stefan Niehues1, Hildrun Haibel1, Valeria Rios Rodriguez1, Murat Torgutalp1, Mikhail Protopopov1, Fabian Proft1, Judith Rademacher1, Joachim Sieper1, Martin Rudwaleit2, Bernd Hamm1, Markus Makowski1, Kay-Geert Hermann1 and Denis Poddubnyy3, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Department of Internal Medicine and Rheumatology, Klinikum Bielefeld, Germany, 3Charité – Universitätsmedizin Berlin, Berlin, Germany

Meeting: ACR Convergence 2020

Keywords: Scleroderma, Spondylarthropathies, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes III: Imaging in SpA (2018–2022)

Session Type: Abstract Session

Session Time: 5:00PM-5:50PM

Background/Purpose: Conventional radiography of the sacroiliac joints is still recommended as the first imaging method if axial spondyloarthritis (axSpA) is suspected. Furthermore, radiographic sacroiliitis is included – together with sacroiliitis on magnetic resonance imaging – in the Assessment of Spondyloarthritis International Society (ASAS) classification criteria for axSpA. Depending on the presence or absence of definite radiographic sacroiliitis, axSpA can be classified either as radiographic axSpA (r-axSpA, synonymous to ankylosing spondylitis) or non-radiographic axSpA (nr-axSpA). Although conventional radiography of sacroiliac joints still plays an important role in clinical practice and for clinical trials, the reliability of radiographic sacroiliitis assessment has been reported in a number of studies as mostly poor, even if performed by expert readers. Furthermore, it was shown that untrained local readers perform worse than expert readers specialised in SpA. One possible solution to achieve a comparable high accuracy as an expert on detection of radiographic sacroiliitis, even in non-specialised clinics, could be development of an artificial intelligence-based model for analysis of radiographs.  

The aim of this study was to develop and validate an artificial neural network for the detection of definite radiographic sacroiliitis as a manifestation of axial spondyloarthritis.

Methods: Conventional radiographs of sacroiliac joints from two independent cohorts of patients with axSpA were used. The first cohort (PROOF) consisted of 1669 radiographs and was used for training and validation of a neural network. The second cohort consisted of 100 randomly selected radiographs from GESPIC, which were used as an independent test dataset. In both cohorts all radiographs underwent central reading; the final decision on the presence or absence of definite radiographic sacroiliitis according to the radiographic criterion of the modified New York criteria was used as a reference. For performance evaluation of the neural network, areas under the receiver operating characteristic curves (AUROC) were calculated. Sensitivity and specificity for the prediction cut-offs were calculated. Cohen’s Kappa and the absolute agreement were used to assess the agreement between the neural network and the human readers.

Results: The neural network achieved an excellent performance in recognition of definite radiographic sacroiliitis with AUROC of 0.97 and 0.96 for the validation and test datasets, respectively (Figure 1). Sensitivity and specificity for the cut-off weighting both measurements equally were 0.90 and 0.93 for the validation and 0.87 and 0.97 for the test set. The Cohen’s kappa between the neural network and the reference judgements were 0.80 for both validation and test sets, and the absolute agreement on the classification yielded 91% and 90%, respectively (Table). Examples of the activation maps of the neural network are presented in Figure 2.

Conclusion: Artificial neural networks enable the accurate detection of definite radiographic sacroiliitis relevant for the diagnosis and classification of axSpA.


Disclosure: K. Bressem, None; J. Vahldiek, None; L. Adams, None; S. Niehues, None; H. Haibel, None; V. Rios Rodriguez, None; M. Torgutalp, None; M. Protopopov, None; F. Proft, Novartis, 2, 8, AbbVie, 8, AMGEN, 8, BMS, 8, Hexal, 8, Celgene, 8, Lilly, 8, MSD, 8, Pfizer, 8, Roche, 8, UCB, 8; J. Rademacher, None; J. Sieper, AbbVie, 5, Novartis, 5, 8, Lilly, 8, Janssen, 5, Merck, 5, 8; M. Rudwaleit, Bristol-Myers Squibb, 5, 8, Chugai Pharmaceutical Co., Ltd., 5, 8, Eli Lilly and Company, 5, 8, Janssen, 5, 8, Novartis, 5, 8, UCB Pharma, 5, 8, AbbVie, 5, 8, Pfizer, 5, 8, Celgene, 8, Roche, 5, 8, Merck Sharp & Dohme, 5, 8; B. Hamm, None; M. Makowski, None; K. Hermann, None; D. Poddubnyy, Eli Lilly and Company, 2, 5, 8, MSD, 2, 5, 8, Novartis, 2, 5, 8, Pfizer, 2, 5, 8, BioCad, 5, Gilead, 5, GSK, 5, UCB, 5, 8, BMS, 8.

To cite this abstract in AMA style:

Bressem K, Vahldiek J, Adams L, Niehues S, Haibel H, Rios Rodriguez V, Torgutalp M, Protopopov M, Proft F, Rademacher J, Sieper J, Rudwaleit M, Hamm B, Makowski M, Hermann K, Poddubnyy D. Development and Validation of an Artificial Intelligence Approach for the Detection of Radiographic Sacroiliitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/development-and-validation-of-an-artificial-intelligence-approach-for-the-detection-of-radiographic-sacroiliitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-validation-of-an-artificial-intelligence-approach-for-the-detection-of-radiographic-sacroiliitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology